Business Context and Reporting Period
This Form 6-K filing by Can-Fite Biopharma Ltd. covers the month of June 2024. The report addresses the status of the Company's Annual General Meeting of Shareholders.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice regarding a shareholder meeting and does not contain financial statements.
Material Changes
There are no material financial changes reported in this filing. The primary event is the procedural adjournment of the Annual General Meeting originally scheduled for June 26, 2024, due to a lack of quorum.
Guidance, Outlook, and Management Commentary
Management has announced that the Annual General Meeting will be reconvened on Wednesday, July 3, 2024, at 3:00 p.m. Israel time. The meeting will be held at the Company's offices located at 26 Ben Gurion Street, Ramat Gan, Israel. No financial guidance or risk factors were disclosed in this specific filing.
Key Facts for Investor Verification
- The Annual General Meeting scheduled for June 26, 2024, was adjourned due to a lack of quorum.
- The reconvened meeting is scheduled for July 3, 2024, at 3:00 p.m. Israel time.
- This filing contains no financial performance data or updated business outlook.